Learn more

INST OF MEDICINAL BIOTECHNOLOGY ACADEMY OF MEDICAL SCIENCES

Overview
  • Total Patents
    24
About

INST OF MEDICINAL BIOTECHNOLOGY ACADEMY OF MEDICAL SCIENCES has a total of 24 patent applications. Its first patent ever was published in 2004. It filed its patents most often in China. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and environmental technology are FARMACEUTICI GEYMONAT SUD, OPOS BIOCHIMICA SRL and SUZHOU KANGRUN PHARMACEUTICALS INC.

Patent filings in countries

World map showing INST OF MEDICINAL BIOTECHNOLOGY ACADEMY OF MEDICAL SCIENCESs patent filings in countries
# Country Total Patents
#1 China 24

Patent filings per year

Chart showing INST OF MEDICINAL BIOTECHNOLOGY ACADEMY OF MEDICAL SCIENCESs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Yongsu Zhen 5
#2 Shuying Wu 4
#3 Lianshun Feng 3
#4 Huiyuan Guo 3
#5 Siyang Ni 3
#6 Zhuorong Li 3
#7 Mingliang Liu 3
#8 Yiguang Wang 3
#9 Jiandong Jiang 3
#10 Shuyi Si 2

Latest patents

Publication Filing date Title
CN102604969A Enterovirus 71 cDNA (complementary deoxyribose nucleic acid) infectious clone as well as construction method and application of enterovirus 71 cDNA infectious clone
CN102579437A Tacrolimus composition containing alcohol and preparation method of tacrolimus composition
CN102391183A C-19 modified geldanamycin(GDM) derivatives and preparation method thereof
CN102329315A Fluoro methoxyimino-substituted nalidixic carboxylic acid compound and preparation method thereof
CN102321082A Naphthyridinone carboxylic acid compound and preparation method thereof
CN102702164A Human ATP-binding cassette transporter A1 activity regulator screening model and application thereof
CN102578039A Zebrafish liver replication model for human HCV (hepatitis C virus) genes
CN102101867A Thiazinogeldanamycin and preparation method and use thereof
CN102030764A 4,5-dihydro-thiazinogeldanamycin and preparation method thereof
CN102406634A Human immunodeficiency virus (HIV)-1 integrase inhibitor
CN101810860A Medicinal composition having tumor-resistant synergy
CN101812063A Alpha-naphthalenesulfonamide base quintuple heterocyclic compound and anti-tumor activity thereof
CN101812052A Quinoline carboxylic acid derivative containing isatin substitute and preparation method thereof
CN102160523A Method for producing pinellia ternate embryoid and tissue culture seedling
CN101554472A Novel medical compound being capable of synergetically suppressing growth of tumors
CN101880222A Square acid derivate and preparation method thereof
CN101475643A Double single chain antibody strengthened fusion protein dFv-LDP-AE, preparation and use thereof
CN101629901A Composition and method for screening antituberculosis medicaments
CN101608200A Preparation method capable of improving boningmycin yield
CN101259287A Application of LDP protein as tumor target medicine guiding carrier